Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 241 AL 255

Drugs targeting APOE4 that regulate beta-amyloid aggregation in the brain: Therapeutic potential for Alzheimer's disease

Poblano J, Castillo-Tobías I, Berlanga L, Tamayo-Ordoñez MC, Del Carmen Rodríguez-Salazar M, Silva-Belmares SY, Aguayo-Morales H, Cobos-Puc LE.

Basic Clin Pharmacol Toxicol. 2024 Sep;135(3):237-249. doi: 10.1111/bcpt.14055. Epub 2024 Jul 17.

Design of Multi-Target drugs of HDACs and other Anti-Alzheimer related Targets: Current strategies and future prospects in Alzheimer's diseases therapy

Soltan OM, Abdelrahman KS, Bass AKA, Takizawa K, Narumi A, Konno H.

Bioorg Chem. 2024 Oct;151:107651. doi: 10.1016/j.bioorg.2024.107651. Epub 2024 Jul 15.

Cannabidiol and Alzheimer's disease

Marques BL, Campos AC.

Int Rev Neurobiol. 2024;177:121-134. doi: 10.1016/bs.irn.2024.04.014. Epub 2024 Jul 4.

Iron Chelators and Alzheimer's Disease Clinical Trials

Mandal PK, Maroon JC, Samkaria A, Arora Y, Sharma S, Pandey A.

J Alzheimers Dis. 2024;100(s1):S243-S249. doi: 10.3233/JAD-240605.

The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets

AmeliMojarad M, AmeliMojarad M.

CNS Neurosci Ther. 2024 Jul;30(7):e14856. doi: 10.1111/cns.14856.

Natural products targeting amyloid-β oligomer neurotoxicity in Alzheimer's disease

Gonçalves PB, Sodero ACR, Cordeiro Y.

Eur J Med Chem. 2024 Oct 5;276:116684. doi: 10.1016/j.ejmech.2024.116684. Epub 2024 Jul 14.

Role of astrocytes in Alzheimer's disease pathogenesis and the impact of exercise-induced remodeling

Shao J, Deng Q, Feng S, Wu C, Liu X, Yang L.

Biochem Biophys Res Commun. 2024 Nov 5;732:150418. doi: 10.1016/j.bbrc.2024.150418. Epub 2024 Jul 17.

Mesenchymal stem cell therapy for Alzheimer's disease: A novel therapeutic approach for neurodegenerative diseases

Bhatt A, Bhardwaj H, Srivastava P.

Neuroscience. 2024 Sep 13;555:52-68. doi: 10.1016/j.neuroscience.2024.07.019. Epub 2024 Jul 19.

Evolving significance of kinase inhibitors in the management of Alzheimer's disease

Ansari MM, Sahu SK, Singh TG, Singh SRJ, Kaur P.

Eur J Pharmacol. 2024 Sep 15;979:176816. doi: 10.1016/j.ejphar.2024.176816. Epub 2024 Jul 20.

Advances in Understanding and Managing Alzheimer's Disease: From Pathophysiology to Innovative Therapeutic Strategies

Rathee S, Sen D, Pandey V, Jain SK.

Curr Drug Targets. 2024;25(11):752-774. doi: 10.2174/0113894501320096240627071400.

Progress in mitochondrial and omics studies in Alzheimer's disease research: from molecular mechanisms to therapeutic interventions

Liao Z, Zhang Q, Ren N, Zhao H, Zheng X.

Front Immunol. 2024 Jul 8;15:1418939. doi: 10.3389/fimmu.2024.1418939. eCollection 2024.

Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study

Papp KV, Maruff P, Rentz DM, Donohue MC, Liu A, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2024;11(4):846-856. doi: 10.14283/jpad.2024.137.

Safety, Efficacy and Clinical Applications of Focused Ultrasound-Mediated Blood Brain Barrier Opening in Alzheimer's Disease: A Systematic Review

Patwardhan A, Wilkinson T, Meng Y, Alhashyan I, Black SE, Lipsman N, Masellis M.

J Prev Alzheimers Dis. 2024;11(4):975-982. doi: 10.14283/jpad.2024.85.

Improving Cognition Without Clearing Amyloid: Effects of Tau and Ultrasound Neuromodulation

Leinenga G, Padmanabhan P, Götz J.

J Alzheimers Dis. 2024;100(s1):S211-S222. doi: 10.3233/JAD-240616.

Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies

Sun Z, Zhang X, So KF, Jiang W, Chiu K.

Biomolecules. 2024 Jul 11;14(7):833. doi: 10.3390/biom14070833.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias